-+ 0.00%
-+ 0.00%
-+ 0.00%

NERVGEN PHARMA CORP - Q3 NET LOSS WAS C$6.4 MLN, OR C$0.06 PER SHARE

Reuters·11/16/2026 12:15:00

Please log in to view news